Liver Cancer Has a Distinctive Profile in Black Patients: Current Screening Guidelines May Be Inadequate

Adam C. Winters; Tali Shaltiel; Umut Sarpel; Andrea D. Branch

doi:10.1002/hep4.1771

Liver Cancer Has a Distinctive Profile in Black Patients: Current Screening Guidelines May Be Inadequate

Adam C. Winters
, Tali Shaltiel
, Umut Sarpel
, Andrea D. Branch

Research output: Contribution to journal › Editorial

7 Scopus citations

Original language	English
Pages (from-to)	8-11
Number of pages	4
Journal	Hepatology Communications
Volume	6
Issue number	1
DOIs	https://doi.org/10.1002/hep4.1771
State	Published - Jan 2022

Access to Document

10.1002/hep4.1771

Cite this

@article{7f2a68935109429b8d58a29a92e12f65,

title = "Liver Cancer Has a Distinctive Profile in Black Patients: Current Screening Guidelines May Be Inadequate",

author = "Winters, \{Adam C.\} and Tali Shaltiel and Umut Sarpel and Branch, \{Andrea D.\}",

note = "Funding Information: Potential conflict of interest: Dr. Branch and Dr. Sarpel have received funding from the Prevent Cancer Foundation, CDC/NIOSH, NCI, NIDA, NIDDK, Gilead Sciences, and Boehringer Ingelheim. ",

year = "2022",

month = jan,

doi = "10.1002/hep4.1771",

language = "English",

volume = "6",

pages = "8--11",

journal = "Hepatology Communications",

issn = "2471-254X",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Liver Cancer Has a Distinctive Profile in Black Patients

T2 - Current Screening Guidelines May Be Inadequate

AU - Winters, Adam C.

AU - Shaltiel, Tali

AU - Sarpel, Umut

AU - Branch, Andrea D.

N1 - Funding Information: Potential conflict of interest: Dr. Branch and Dr. Sarpel have received funding from the Prevent Cancer Foundation, CDC/NIOSH, NCI, NIDA, NIDDK, Gilead Sciences, and Boehringer Ingelheim.

PY - 2022/1

Y1 - 2022/1

UR - https://www.scopus.com/pages/publications/85115370870

U2 - 10.1002/hep4.1771

DO - 10.1002/hep4.1771

M3 - Editorial

AN - SCOPUS:85115370870

SN - 2471-254X

VL - 6

SP - 8

EP - 11

JO - Hepatology Communications

JF - Hepatology Communications

IS - 1

ER -